Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Repligen Co. (NASDAQ:RGEN – Get Free Report) insider Christine Gebski sold 3,788 shares of the stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $147.13, for a total transaction of $557,328.44. Following the transaction, the insider now owns 28,787 shares in the company, valued at […]
New York State Common Retirement Fund boosted its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 1.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 436,799 shares of the biotechnology company’s stock after purchasing an additional 4,281 shares during […]
Repligen Co. (NASDAQ:RGEN – Free Report) – Stock analysts at Zacks Research decreased their Q3 2023 EPS estimates for shares of Repligen in a note issued to investors on Thursday, October 26th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will earn $0.18 per share for the quarter, down from their prior […]
Geneva Capital Management LLC decreased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 5.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 123,606 shares of the biotechnology company’s stock after selling 6,547 shares during the period. Geneva Capital Management LLC’s holdings in Repligen […]
Repligen Co. (NASDAQ:RGEN – Get Free Report)’s stock price traded up 4.6% during trading on Thursday . The company traded as high as $150.43 and last traded at $149.09. 156,091 shares traded hands during trading, a decline of 72% from the average session volume of 561,980 shares. The stock had previously closed at $142.51. Wall […]